Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 22, 2026 14:30 UTC |
Coastlands Capital LP10% owner
|
PurchaseCommon Stock | 100,000 | $0.53 | $53,000.00 |
DisclosureSEC source: 0001104659-26-076184 · tm2618440-1_4seq1.xml · nonDerivative · entry 1 Coastlands Capital LP · CIK 0002068530 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Coastlands Capital LP Disclosed balance after: 3,835,035 F1 · ownership.nature: Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:41 UTC |
Leahy EmerDirector
|
GrantStock Option (right to buy) · Derivative | 152,783 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001213900-26-052257 · ownership.xml · derivative · entry 1 Leahy Emer · CIK 0001875180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,783 Underlying: Common Stock · 152,783 shares Expires 2036-04-30 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:42 UTC |
STEINMAN LAWRENCEDirector
|
GrantStock Option (right to buy) · Derivative | 152,783 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001213900-26-052261 · ownership.xml · derivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,783 Underlying: Common Stock · 152,783 shares Expires 2036-04-30 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:41 UTC |
Dumesnil SimonDirector
|
GrantStock Option (right to buy) · Derivative | 152,783 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001213900-26-052260 · ownership.xml · derivative · entry 1 Dumesnil Simon · CIK 0001875691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,783 Underlying: Common Stock · 152,783 shares Expires 2036-04-30 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:42 UTC |
Marques TiagoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 1,756,069 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001213900-26-052262 · ownership.xml · derivative · entry 1 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,756,069 Underlying: Common Stock · 1,756,069 shares Expires 2036-04-30 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan). Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:40 UTC |
Novak Alfred JDirector
|
GrantStock Option (right to buy) · Derivative | 152,783 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001213900-26-052256 · ownership.xml · derivative · entry 1 Novak Alfred J · CIK 0001388862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,783 Underlying: Common Stock · 152,783 shares Expires 2036-04-30 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:41 UTC |
Schneiderman Daniel HChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 1,129,323 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001213900-26-052259 · ownership.xml · derivative · entry 1 Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,129,323 Underlying: Common Stock · 1,129,323 shares Expires 2036-04-30 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan). Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:41 UTC |
Krishnan KartikChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 1,129,323 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001213900-26-052258 · ownership.xml · derivative · entry 1 Krishnan Kartik · CIK 0002131061 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,129,323 Underlying: Common Stock · 1,129,323 shares Expires 2036-04-30 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan). Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 13:51 UTC |
Leahy EmerDirector
|
GrantCommon Stock | 33,333 | $0.75 | $24,999.75 |
DisclosureSEC source: 0001213900-25-116296 · ownership.xml · nonDerivative · entry 1 Leahy Emer · CIK 0001875180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,333 Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 14:07 UTC |
STEINMAN LAWRENCEDirector
|
PurchaseCommon Stock | 133,333 | $0.75 | $99,999.75 |
DisclosureSEC source: 0001213900-25-116309 · ownership.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,691 Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 13:54 UTC |
Dumesnil SimonDirector
|
PurchaseCommon Stock | 33,333 | $0.75 | $24,999.75 |
DisclosureSEC source: 0001213900-25-116299 · ownership.xml · nonDerivative · entry 1 Dumesnil Simon · CIK 0001875691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,833 Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 13:56 UTC |
Marques TiagoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 33,333 | $0.75 | $24,999.75 |
DisclosureSEC source: 0001213900-25-116301 · ownership.xml · nonDerivative · entry 1 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,334 Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 14:04 UTC |
Schneiderman Daniel HChief Financial Officer
|
GrantCommon Stock | 26,667 | $0.75 | $20,000.25 |
DisclosureSEC source: 0001213900-25-116306 · ownership.xml · nonDerivative · entry 1 Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,667 Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 21:26 UTC |
Leahy EmerDirector
|
GrantStock Option (right to buy) · Derivative | 42,913 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001213900-25-102676 · ownership.xml · derivative · entry 1 Leahy Emer · CIK 0001875180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,913 Underlying: Common Stock · 42,913 shares Expires 2035-10-23 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 21:27 UTC |
STEINMAN LAWRENCEDirector
|
GrantStock Option (right to buy) · Derivative | 242,913 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001213900-25-102682 · ownership.xml · derivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,913 Underlying: Common Stock · 242,913 shares Expires 2035-10-23 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 21:25 UTC |
Dumesnil SimonDirector
|
GrantStock Option (right to buy) · Derivative | 42,913 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001213900-25-102674 · ownership.xml · derivative · entry 1 Dumesnil Simon · CIK 0001875691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,913 Underlying: Common Stock · 42,913 shares Expires 2035-10-23 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 21:26 UTC |
Marques TiagoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 493,341 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001213900-25-102677 · ownership.xml · derivative · entry 1 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 493,341 Underlying: Common Stock · 493,341 shares Expires 2035-10-23 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan). Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 21:26 UTC |
Novak Alfred JDirector
|
GrantStock Option (right to buy) · Derivative | 42,913 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001213900-25-102680 · ownership.xml · derivative · entry 1 Novak Alfred J · CIK 0001388862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,913 Underlying: Common Stock · 42,913 shares Expires 2035-10-23 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Read SEC document |
| October 24, 2025 Filed Oct 27, 2025 21:27 UTC |
Schneiderman Daniel HChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 317,266 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001213900-25-102681 · ownership.xml · derivative · entry 1 Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,266 Underlying: Common Stock · 317,266 shares Expires 2035-10-23 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan). Read SEC document |
| May 12, 2025 Filed May 15, 2025 01:55 UTC |
Marques TiagoDirector · Chief Executive Officer
|
SaleCommon Stock | 960 | $0.83 | $792.00 |
DisclosureSEC source: 0001213900-25-043621 · ownership.xml · nonDerivative · entry 1 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,001 F1 · shares: The Reporting Person previously held 960 shares of Common Stock of the Issuer in a foreign brokerage account that was recently wound down. As a result, the foreign broker automatically liquidated the Reportion Person's account on May 12, 2025 by selling the 960 shares of Common Stock of the Issuer on a non-discretionary basis. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 21:25 UTC |
Novak Alfred JDirector
|
GrantCommon Stock | 2,750 | $5.62 | $15,455.00 |
DisclosureSEC source: 0001213900-24-053005 · ownership.xml · nonDerivative · entry 2 Novak Alfred J · CIK 0001388862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,500 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.55 to $5.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 21:25 UTC |
Novak Alfred JDirector
|
GrantCommon Stock | 750 | $5.61 | $4,207.50 |
DisclosureSEC source: 0001213900-24-053005 · ownership.xml · nonDerivative · entry 1 Novak Alfred J · CIK 0001388862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.60 to $5.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:46 UTC |
Leahy EmerDirector
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001213900-24-019218 · ownership.xml · derivative · entry 1 Leahy Emer · CIK 0001875180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-02-28 F1 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:47 UTC |
STEINMAN LAWRENCEDirector
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001213900-24-019222 · ownership.xml · derivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-02-28 F1 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:45 UTC |
Dumesnil SimonDirector
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001213900-24-019217 · ownership.xml · derivative · entry 1 Dumesnil Simon · CIK 0001875691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-02-28 F1 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:46 UTC |
Marques TiagoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 11,669 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001213900-24-019219 · ownership.xml · derivative · entry 2 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,669 Underlying: Common Stock · 11,669 shares Expires 2034-02-28 F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:46 UTC |
Marques TiagoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001213900-24-019219 · ownership.xml · derivative · entry 1 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-02-28 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains a director or otherwise in continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:46 UTC |
Novak Alfred JDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001213900-24-019220 · ownership.xml · derivative · entry 1 Novak Alfred J · CIK 0001388862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-02-28 F1 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:46 UTC |
Schneiderman Daniel HChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 5,927 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001213900-24-019221 · ownership.xml · derivative · entry 2 Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,927 Underlying: Common Stock · 5,927 shares Expires 2034-02-28 F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:46 UTC |
Schneiderman Daniel HChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001213900-24-019221 · ownership.xml · derivative · entry 1 Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-28 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 02:45 UTC |
Currie Graeme MartinChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 5,938 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001213900-24-019216 · ownership.xml · derivative · entry 1 Currie Graeme Martin · CIK 0001965006 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,938 Underlying: Common Stock · 5,938 shares Expires 2034-02-28 F1 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The Option fully vested upon issuance and became exercisable on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment |
Leahy EmerDirector
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001213900-24-030962 · ownership.xml · derivative · entry 1 Leahy Emer · CIK 0001875180 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-02-28 F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share. F2 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment |
STEINMAN LAWRENCEDirector
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001213900-24-030957 · ownership.xml · derivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-02-28 F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share. F2 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment |
Dumesnil SimonDirector
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001213900-24-030958 · ownership.xml · derivative · entry 1 Dumesnil Simon · CIK 0001875691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-02-28 F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share. F2 · derivative.exercise_date: The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment |
Marques TiagoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 11,669 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001213900-24-030963 · ownership.xml · derivative · entry 2 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,669 Underlying: Common Stock · 11,669 shares Expires 2034-02-28 F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share. F3 · derivative.exercise_date: The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment |
Marques TiagoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001213900-24-030963 · ownership.xml · derivative · entry 1 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-02-28 F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share. F2 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of Common Stock underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains a director or otherwise in continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment |
Novak Alfred JDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001213900-24-030960 · ownership.xml · derivative · entry 1 Novak Alfred J · CIK 0001388862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-02-28 F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share. F2 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment |
Schneiderman Daniel HChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 5,927 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001213900-24-030961 · ownership.xml · derivative · entry 2 Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,927 Underlying: Common Stock · 5,927 shares Expires 2034-02-28 F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share. F3 · derivative.exercise_date: The option award was made in accordance with the terms of the 2023 Plan. The option award fully vested upon issuance and became exercisable on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment |
Schneiderman Daniel HChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001213900-24-030961 · ownership.xml · derivative · entry 1 Schneiderman Daniel H · CIK 0001565536 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-28 F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share. F2 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan (the "2023 Plan"). The shares of Common Stock underlying the option award will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Apr 6, 2024 01:45 UTC Amendment |
Currie Graeme MartinChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 5,938 | $0.00 Strike: $8.13 | $0.00 |
DisclosureSEC source: 0001213900-24-030959 · ownership.xml · derivative · entry 1 Currie Graeme Martin · CIK 0001965006 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,938 Underlying: Common Stock · 5,938 shares Expires 2034-02-28 F1 · derivative.exercise_price: The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share. F2 · derivative.exercise_date: The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The Option fully vested upon issuance and became exercisable on March 1, 2024. Read SEC document |
| June 02, 2023 Filed Jun 7, 2023 01:00 UTC |
STEINMAN LAWRENCEDirector
|
PurchaseCommon Stock | 30,000 | $0.43 | $12,930.00 |
DisclosureSEC source: 0001493152-23-020333 · ownership.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,327,174 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.38 to $0.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 28, 2022 Filed Nov 28, 2022 21:00 UTC |
STEINMAN LAWRENCEDirector
|
GrantCommon Stock | 5,000 | $0.98 | $4,900.00 |
DisclosureSEC source: 0001213900-22-075491 · ownership.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,287,174 Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 21:00 UTC |
Marques TiagoDirector · Chief Executive Officer
|
GrantCommon Stock | 2,000 | $1.03 | $2,060.00 |
DisclosureSEC source: 0001213900-22-075490 · ownership.xml · nonDerivative · entry 4 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 819,206 Read SEC document |
| November 23, 2022 Filed Nov 28, 2022 21:00 UTC |
Marques TiagoDirector · Chief Executive Officer
|
GrantCommon Stock | 1,206 | $1.02 | $1,230.12 |
DisclosureSEC source: 0001213900-22-075490 · ownership.xml · nonDerivative · entry 3 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 817,206 Read SEC document |
| November 23, 2022 Filed Nov 28, 2022 21:00 UTC |
Marques TiagoDirector · Chief Executive Officer
|
GrantCommon Stock | 1,000 | $1.03 | $1,030.00 |
DisclosureSEC source: 0001213900-22-075490 · ownership.xml · nonDerivative · entry 2 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,000 Read SEC document |
| November 23, 2022 Filed Nov 28, 2022 21:00 UTC |
Marques TiagoDirector · Chief Executive Officer
|
GrantCommon Stock | 5,000 | $1.00 | $5,000.00 |
DisclosureSEC source: 0001213900-22-075490 · ownership.xml · nonDerivative · entry 1 Marques Tiago · CIK 0001875240 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 815,000 Read SEC document |
| November 22, 2022 Filed Nov 22, 2022 21:10 UTC |
STEINMAN LAWRENCEDirector
|
GrantCommon Stock | 5,000 | $0.99 | $4,950.00 |
DisclosureSEC source: 0001213900-22-074585 · ownership.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,282,174 Read SEC document |
| November 17, 2022 Filed Nov 17, 2022 21:34 UTC |
Dumesnil SimonDirector
|
GrantCommon Stock | 40,000 | $1.06 | $42,400.00 |
DisclosureSEC source: 0001213900-22-073502 · ownership.xml · nonDerivative · entry 2 Dumesnil Simon · CIK 0001875691 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:34 UTC |
Dumesnil SimonDirector
|
GrantCommon Stock | 10,000 | $1.07 | $10,700.00 |
DisclosureSEC source: 0001213900-22-073502 · ownership.xml · nonDerivative · entry 1 Dumesnil Simon · CIK 0001875691 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| October 26, 2022 Filed Oct 26, 2022 21:35 UTC |
STEINMAN LAWRENCEDirector
|
GrantCommon Stock | 5,000 | $1.10 | $5,500.00 |
DisclosureSEC source: 0001213900-22-066554 · ownership.xml · nonDerivative · entry 1 STEINMAN LAWRENCE · CIK 0001132679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,277,174 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.